You are on page 1of 20

CERTIFIED PHARMACEUTICAL

CPGP
GOOD MANUFACTURING
PRACTICES PROFESSIONAL

Quality excellence to enhance your career


and boost your organization’s bottom line
asq.org/cert
Certification from ASQ is considered a mark of quality
excellence in many industries. It helps you advance
your career, and boosts your organization’s bottom line
through your mastery of quality skills. Becoming certified
as a Pharmaceutical GMP Professional confirms your
commitment to quality and the positive impact it will
have on your organization.

Examination
Each certification candidate
is required to pass a written
examination that consists of
multiple-choice questions that
measure comprehension of
the body of knowledge.

2 Certified Pharmaceutical GMP Professional


INFORMATION
Certified Pharmaceutical Good
Manufacturing Practices Professional
The Certified Pharmaceutical Good Manufacturing Practices Professional
(CPGP) understands the GMP principles as regulated and guided by national
and international agencies for the pharmaceutical industry. This covers finished
human and veterinary drugs and biologics, ectoparasitacides, and dietary
supplements (alternatively called nutraceuticals where regulated as drug products),
as well as their component raw materials (includes active pharmaceutical
ingredients (APIs) and excipients) and packaging and labeling operations.

CPGP Education and/or Experience


Computer Delivered – The CPGP You must have five years of on-the-
examination is a one-part, 165 job experience in one or more of the
multiple-choice question, four-and- areas of the Certified Pharmaceutical
a-half-hour exam and is offered in GMP Professional Body of Knowledge.
English only. One hundred and A minimum of three years of this
fifty questions are scored and 15 experience must be in a decision-making
are unscored. position. “Decision-making” is defined
as the authority to define, execute, or
Paper and Pencil – The CPGP
control projects/processes and to be
examination is a one-part, 150
responsible for the outcome. This may
multiple-choice question, four-hour
or may not include management or
exam and is offered in English only.
supervisory positions. There are no
education waivers for this exam.

For comprehensive exam information on the Pharmaceutical GMP Professional


certification, visit asq.org/cert.
Certified Pharmaceutical GMP Professional 3
Minimum Expectations • Will be able to apply requirements,
specifications, and qualification
• Will have a fundamental and validation for construction
understanding of requirements and maintenance of facilities,
and consequences of utilities, and equipment. Evaluate
noncompliance of regulatory automated or computerized systems,
agency governance, including and apply business continuity plans,
global regulatory framework, disaster recovery techniques, and
relevant regulations and change management.
guidelines, and mutual
recognition agreements. • Will be able to apply sampling
plans and procedures for shipping
• Will be able to understand, and receiving materials, analyze
apply, and evaluate elements in-house storage, identification,
and requirements of a quality and rotation of materials, and
system. Will be able to meet requirements for materials
understand and evaluate self- traceability and sourcing, including
inspection, audits, and supplier returned goods.
management. Will be able to
evaluate records, documents, • Will have a thorough under-
and reports created within standing of sterile and nonsterile
these quality systems. requirements of manufacturing
systems and be able to analyze
• Will be able to understand, master and completed batch records,
apply, analyze, and evaluate material control procedures, and
requirements, specifications, contamination controls.
and data relating to laboratory
systems, including relevant • Will be able to create and evaluate
compendia for the United States, filling, packaging, and labeling
Europe, and Japan, investigations operations and controls.
of atypical laboratory results, and • Will have a fundamental
instrument control and record- understanding of product design
keeping. Must be able to apply factors and phase-appropriate
and evaluate stability and sample GMP requirements. Will have
retain programs. a thorough understanding of
technology transfer activities.

4 Certified Pharmaceutical GMP Professional


BODY OF KNOWLEDGE
Certified Pharmaceutical GMP Professional (CPGP)
Topics in this body of knowledge (BoK) cover compliance with
good manufacturing practices (GMPs), as regulated and guided
by national and international agencies for the pharmaceutical
industry. It covers finished human and veterinary drugs and biologics,
and combination devices, as well as their component raw materials
(including active pharmaceutical ingredients (APIs) and excipients),
and packaging and labeling operations.
This BoK includes subtext explanations and corresponding cognitive
levels for each topic or subtopic. These details will be used by the
Examination Development Committee as guidelines for writing test
questions and are designed to help candidates prepare for the
exam by identifying specific content that can be tested. The subtext
is not intended to limit the subject matter or be all-inclusive of what
might be covered in an exam but is intended to clarify how topics
relate to the role of the Certified Pharmaceutical GMP Professional
(CPGP). The descriptor in parentheses at the end of each subtext
entry refers to the highest cognitive level at which the topic will be
tested. A more complete description of cognitive levels is provided
at the end of this document.

I. Regulatory Agency the International Conference on


Harmonization (ICH), the European
Governance (15 Questions) Medicines Agency (EMA), the
Food & Drug Administration (FDA),
A. Global Regulatory Framework the USDA 9CFR, the International
Identify the acts, statutes, Pharmaceutical Excipients Council
and directives that apply to (IPEC), and Controlled Substance Act
pharmaceuticals. (Understand) (CSA) 21 CFR 1300. (Understand)

B. Regulations and Guidances C. Mutual Recognition Agreements


Interpret frequently used regulations Interpret requirements that govern
and guidelines/guidances, including product registration, import or export
those published or administered of raw material or finished product,
by the Pharmaceutical Inspection and the sharing of inspection
Convention and Pharmaceutical findings. (Understand)
Inspection Cooperation Scheme
(PIC/S), Health Canada, the World
Health Organization (WHO),

Certified Pharmaceutical GMP Professional 5


D. Regulatory Inspections (QMS), the requirements for the
Define and describe various development and operation and
types of inspections including management review for suitability
what triggers them, their frequency, and effectiveness as defined in
and the inspection process used ICH Q10, EU GMP, and other
for inspections such as pre-approval, guidances. (Evaluate)
system-based, for-cause, and license
renewal. (Understand) B. Quality Unit (Site) Management
Describe quality management
E. Enforcement Actions elements for individual sites or units,
Define and describe various global including responsibilities for the quality
enforcement actions and consequences unit management such as qualified
(e.g., warning letters, consent decree, persons, batch release requirements,
license withdrawals, product seizure, and the need for quality units to
and import alerts). (Understand) be independent from operations.
(Understand)
F. Regulatory Agency Reporting
C. Risk Management
1. Post-marketing changes
Use various methods to apply risk
Describe how post-marketing management principles, as described
changes to specifications, processes, in ICH Q9 and other guidance or
methods, are assessed for impact to regulatory documents. (Apply)
determine the appropriate reporting
method [e.g., scale up and post
approval changes (SUPAC)]. D. Training and
(Understand) Personnel Qualification
1. Needs analysis
2. Regulatory reporting requirements
Identify the requirements for
Describe global reporting determining the type of training,
requirements, including supplements, qualification, and/or experience
field alerts, biological product needed by quality staff members,
deviation reports, adverse events, operations personnel and related
product recalls, annual reports, functions. (Understand)
and variations to dossiers and
applications. (Understand) 2. Staff development requirements
Determine proof of proficiency
3. Product surveillance
based on regulations, guidances,
Describe monitoring require- and directives including
ments for risk evaluation and documented evidence and
mitigation strategy (REMS) and periodic reassessment. (Apply)
pharmacovigilance. (Understand)
E. Change Control and Management
G. Site Master File (SMF),
1. Pre-change analysis
Validation Master Plan (VMP)
Assess the impact that proposed
and Drug Master File (DMF) changes will have on products,
and Site Reference File (SRF) processes, facilities, utilities, systems,
Describe the purpose and content to ensure risk minimization and
of these files. (Understand) regulatory compliance. (Analyze)

2. Post-change analysis
II. Quality Systems
Analyze data and other inputs to
(27 Questions) determine the results of a change,
and evaluate any new risk factors
A. Quality Management created by the change. (Analyze)
System (QMS)
Describe key elements of the structure
of a quality management system

6 Certified Pharmaceutical GMP Professional


F. Investigations and Corrective I. Product Complaints
and Preventive Action (CAPA) and Adverse Event Reports
1. Trigger events 1. Product complaints
Identify events that require: Describe and distinguish between
investigation, root cause analysis, product complaints and adverse
and impact assessment both events, and evaluate complaint-
directly and indirectly related handling processes. (Evaluate)
to the event. (Evaluate)
2. Adverse events
2. Response actions Describe regulatory requirements
Define immediate action, for the reporting of adverse events.
corrective action, preventive (Analyze)
action, management responsibility,
and methods of implementing 3. Event response
them. (Evaluate) Evaluate the level of action that
needs to be taken in response to
3. CAPA feedback and trending these types of events, including
Describe how CAPA trending is corrections, product removal.
used to modify appropriate quality (Evaluate)
system elements. (Create)
J. Product Trend Requirements
G. Audits and Self-inspections Describe and distinguish between
1. Audits processes and results components of periodic product
assessment, such as the U.S. annual
Differentiate between various
product review (APR) and the European
audit types (systems, product,
product quality review (PQR), with
process) and analyze audit
regard to data trends and other
results to assess conformance
required elements. (Understand)
to requirements. (Evaluate)

2. Audit follow-up K. Supplier and Contractor


Use various methods to evaluate Quality Management
and verify the effectiveness of 1. Supplier quality systems
corrective actions taken. (Evaluate)
Identify and interpret standards and
regulations related to monitoring
H. Documents and supplier and contractor quality
Records Management management systems. (Understand)
1. GMP document system
2. Supplier controls
Describe the GMP document
Assess the adequacy of controls
system to determine compliance to
over supplier selection and
regulatory requirements, including
procurement and receipt of raw
corporate standards, master plans,
materials, components, and
procedures, manufacturing and test
contract services. Determine the
instructions. (Analyze)
need for formal contracts/quality
2. Records agreements. (Evaluate)
Review various records (log 3. Supplier evaluation
books, tags, training evidence)
Assess the quality systems of
to confirm compliance to
suppliers and contractors using
requirements. (Analyze)
various methodologies, including
3. Record retention supplier qualification, certification,
evaluation, audit, as well as
Identify regulatory requirements for
supplied product or service
record retention. (Understand)
performance trending. (Evaluate)

Certified Pharmaceutical GMP Professional 7


III. Laboratory Systems 2. Atypical results
Identify, analyze, and interpret
(21 Questions) data on processes or products that
A. Compendia (United States, are out-of-specification or out-of-
trend, and determine the outcome
Europe, and Japan) of the laboratory portion of the
1. Required vs. investigation and the criteria for
informational compendia further investigation. (Evaluate)
Describe and distinguish between
required and informational (“general”) C. Instrument Management
compendial chapters. (Apply) 1. Instrument controls
2. Marketing requirements Apply operating procedures
vs. compendia for instrument identification,
classification, qualification,
Distinguish among the U.S. calibration, and preventive
Pharmacopoeia (USP), European maintenance. (Apply)
Pharmacopoeia (PhEur or EP) and
Japanese Pharmacopoeia (JP) in 2. Instrument calibration
terms of requirements for marketing Determine that instruments are
authorization. (Understand) calibrated within the specified
3. Compendial methods review range of operation, and they are
accurate and precise. (Apply)
Review compendial methods to
ensure that they are verified as
suitable for use in the testing lab. D. Specifications
(Evaluate) 1. Types of specifications
Determine whether approved
4. Compendial or noncompendial specifications exist for raw
requirements review materials, intermediates,
Review test methods, qualifications, packaging components, labels,
validation and verification against and finished products. (Analyze)
required compendial chapters
(general and informational as 2. Test data and specifications
needed). (Analyze) Compare test data with specifications
to determine whether raw materials,
5. Biological, microbiological, intermediates, packaging, labels,
chemical, and physical and finished products meet
test methods requirements. (Analyze)
Identify and interpret results from
compendia identification tests, 3. Specifications revision
quantitative analysis, qualitative Review and update specifications
analysis, and other tests or studies when methods are revised or
for biological, microbiological, and compendia are changed. (Evaluate)
chemical, and physical tests. (Apply)
E. Laboratory Record-keeping
B. Laboratory Investigations and Data Requirements
of Atypical Results 1. Record-keeping requirements
1. Test data Identify and review record-keeping
Describe and develop procedures requirements for data acquisition
for investigating each type of systems to ensure data integrity.
test data including biological, (Apply)
microbiological, chemical test,
and unknowns. (Analyze) 2. Record review
Review laboratory records to
detect errors or falsification, to
prevent loss of data and ensure
data integrity. (Apply)

8 Certified Pharmaceutical GMP Professional


3. Certificates of analysis (COAs) temperature, humidity, light
Review COAs to ensure they are exposure, absence of oxygen) to
complete, internally reviewed, and maintain the material’s characteristics
appropriately retained. (Apply) for testing. (Apply)

F. Laboratory Handling Controls G. Stability Programs


1. Sample handling 1. Release tests vs.
Determine whether samples stability-indicating tests
are identified and handled in Define and distinguish between
accordance with requirements, these two types of tests. (Apply)
including name, sample
identification, chain of custody. 2. Stability test data
(Apply) Review stability data against
specifications and identify trends
2. Reagents, solutions, that can establish, support,
and standards identification or challenge an expiry date.
Determine whether reagents, (Evaluate)
solutions, and standards are
identified and labeled in 3. Stability-point failure
accordance with requirements, Identify the stability-point failure
including opened-on, expiry, of a product or material, and
(validated) use-by, or recertify-by evaluate the implications for
dates. (Apply) regulatory compliance. (Evaluate)

3. Storage requirements H. Reserve Samples and Retains


Describe and use procedures to Describe the various regulatory
store samples, reagents, solutions, requirements for retains and reserve
and standards in appropriate samples. (Apply)
environmental conditions (e.g.,

Certified Pharmaceutical GMP Professional 9


IV. Infrastructure: Facilities, 3. Utility design for production
Identify and select utility designs
Utilities, Equipment related to production steps (e.g.,
(17 Questions) washing, sterilizing, depyrogenation)
for use with specific materials and
A. Facilities processes. (Apply)
1. Buildings
4. Utilities design specifications
Determine requirements for
appropriate size and construction Review operations of utilities to
of buildings and areas as well as ensure that they meet design
location of control systems. Ensure specifications. (Apply)
that construction and location
5. Utilities change control
facilitate proper operation and
minimize the risk of error and Verify that change control practices
cross contamination (including are in use to maintain the qualified
requirements to specify separation state of affected utilities. (Apply)
of antibiotics, hormones, toxins).
(Apply) C. Equipment
1. Equipment planning
2. Manufacture and
Review equipment location,
storage environment
design, construction, installation,
Identify requirements for appropriate and maintenance based on the
lighting, ventilation, and drainage operations to be conducted. (Apply)
to avoid adversely affecting product
(either directly or indirectly) during 2. Equipment layout
manufacture and storage. (Apply) Determine the layout of
equipment to minimize the risk
3. Facilities change control
of errors, to facilitate effective
Use various methods to verify that cleaning and maintenance, and
change control practices are in to avoid contamination or any
use to maintain the qualified state other undesired effect on product
of the facilities. (Apply) quality. (Apply)

B. Utilities 3. Equipment cleaning


1. Water supply systems and maintenance
Identify and interpret regulatory Review procedures and
requirements for design of water schedules for equipment
supply systems, including various cleaning, maintenance, and,
unit operations (e.g., dechlorination, where necessary, sanitization
reverse osmosis, deionization, to ensure that they meet
distillation), delivery lines, back-flow requirements. (Apply)
or back-siphonage prevention, and
drainage systems, as appropriate for 4. Equipment cleaning
the type of water (potable, purified, validation or verification
water for injection) needed in Evaluate the need and
various processing steps. (Apply) methodology for product-
contact cleaning validation
2. Compressed air and gas systems and/or verification. (Evaluate)
Identify and apply regulatory
requirements related to compressed 5. Equipment change control
air and gas systems, including Verify that change control has
storage, flow regulation, filtration, maintained the qualified state of
venting, and purging. (Apply) equipment. (Apply)

10 Certified Pharmaceutical GMP Professional


D. Qualification and Validation 4. Sterilization processes
Verify that the qualifications and Verify that appropriate sterilization
validations of facilities, equipment, processes are in place and
and utilities are conducted in validated. (Apply)
accordance with various requirements,
including factory and site acceptance G. Automated or
testing (FAT/SAT), design, installation,
Computerized Systems
operational, and performance
qualification (DQ/IQ/OQ/PQ) 1. Validation procedures
prior to process validation. (Analyze) Review procedures for validation
of automated or computerized
E. Maintenance and systems. Verify that critical
Metrology Systems parameters for their operation
and maintenance are controlled
1. Maintenance procedures and monitored. (Evaluate)
Verify that procedures are in
use for routine and non-routine 2. Open and closed
maintenance of heating, ventilation, computerized systems
air conditioning (HVAC) systems; Distinguish between open and
air and water filters; and other closed computerized systems.
equipment and utilities. (Analyze) (Apply)
2. Metrology change control 3. Configuration control
Verify that appropriate calibration Verify that version control and
and engineering/equipment change configuration are maintained and
control procedures are in use, and monitored. (Evaluate)
that a metrology program exists
for the calibration of instruments 4. Security requirements
that control manufacturing facilities, Evaluate computerized systems
utilities, and equipment. (Analyze) to ensure they meet regulatory
and guidance requirements for
F. General Cleaning, Sanitization, key elements, such as access
and Sterilization Systems control, data protection, electronic
signature, change control,
1. Cleaning procedures
data archiving, maintenance,
Review cleaning procedures transcription, audit trail, and
in accordance with cleaning periodic system monitoring.
validation, whenever validation is (Evaluate)
required and performed. (Apply)

2. Sanitization procedures H. Business Continuity and


Review sanitization procedures Disaster Recovery Planning
for facilities and equipment, and 1. Supply chain impact
ensure all are in accordance with Review plans and verify procedures
any required validation studies, for disaster recovery and business
including details on cleaning continuity that will guard operations
schedules, methods, equipment, from interruption to the supply
materials, sanitizers, disinfectants, chain. (Evaluate)
sporicides, and sterilants. (Apply)
2. Contingency plan
3. Pest control Verify the testing and effectiveness
Review and verify that a pest of contingency plans as required
control program is in place and or proceduralized. (Apply)
that it uses authorized rodenticides,
insecticides, fungicides, fumigating
agents, and appropriate traps for
pest elimination. (Apply)

Certified Pharmaceutical GMP Professional 11


V. Materials and Supply appropriate sample size, and
test or inspection criteria. (Apply)
Chain Management
2. Sampling environment
(17 Questions)
Differentiate and apply the
A. Receipt of Materials requirements for sampling
1. Incoming materials environment and utensils to
the type of the material being
Describe and use processes to
sampled. (Apply)
receive and store incoming materials
(raw materials, bulk chemicals, 3. Cleaning
components, labels) and take
Ensure that the sampling
appropriate action on deviations
environment is appropriately
(damaged materials, materials
cleaned and monitored and
from unapproved suppliers,
that sampling utensils are
missing documentation). (Apply)
appropriately cleaned or
2. Inventory controls are single-use. (Apply)
Describe and use procedures for
documenting inventory transactions, C. Material Storage,
material status, allocation, and “stop Identification, and Rotation
shipments” for quality holds. (Apply) 1. Storage suitability
Ensure that the storage environment
B. Sampling Processes is suitable, controlled, and monitored
1. Sampling plans as required for the type of materials.
Review sampling plans for (Apply)
representative sampling,

12 Certified Pharmaceutical GMP Professional


2. Storage labels E. Traceability and Sourcing
Confirm that the identification label 1. Traceability requirements
for stored materials contains the
Define and differentiate the
required information. (Apply)
requirements for traceability of
3. Stock rotation incoming materials, intermediates,
and finished drugs. (Apply)
Define and use stock rotation
requirements, such as first-in/first- 2. Biological agent requirements
out (FIFO) and first-expired/first out
Identify and apply the requirements
(FEFO). (Apply)
related to biological agents such
4. Retest dates vs. expiration dates as bovine and transmissible
spongiform encephalopathy (BSE
Describe the difference between and TSE). (Apply)
retest dates and expiration dates.
(Understand) 3. Pedigree and
sourcing requirements
5. Mix-up risk
Identify and apply requirements for
Identify potential sources of
maintaining pedigree and sourcing
mix-up and identify methods
details for active pharmaceutical
to minimize their risk (material
ingredients (APIs), biological starting
segregation, labeling, special
materials, excipients, intermediates,
storage for rejects, control of
finished products and document the
material returns, lot-control
supply chain, from raw materials
methods, special process for
through wholesale or retail to end
materials with similar names).
user. (Apply)
(Analyze)

D. Shipping and Distribution F. Salvaged/Returned Goods


and Destruction
1. Temperature-sensitive requirements
1. Disposition
Identify special requirements for
temperature-sensitive products, Review salvaged and returned
including tertiary packaging goods and evaluate them for
design, and monitoring devices. disposition. (Evaluate)
(Analyze)
2. Destruction facilities and processes
2. Special requirements Determine the destruction
Determine specific product requirements for materials including
requirements and apply them to suitable facilities and processes.
routine shipping processes. (Apply) (Apply)

3. Report requirements VI. Sterile and Nonsterile


Analyze shipping reports and
transportation requirements in Manufacturing Systems
accordance with good distribution (22 Questions)
practices. (Analyze)
A. Master Batch and
4. Supply chain security Completed Batch Records
Identify and apply the various 1. Required elements
means to secure the supply
chain (tamper-evident seals, Review batch records for
shipping manifests, verification of required elements, including
documentation, barcoding, radio proper issuance, sections on
frequency identification (RFID), yields, critical manufacturing step
serialization). (Apply) verification, processing instructions,
and hold times. (Apply)

Certified Pharmaceutical GMP Professional 13


2. Record processing requirements 2. Dispensing materials
Confirm that batch records meet Identify the requirements for
requirements for execution, review, using weighing equipment and
and disposition decisions. (Apply) handling utensils for dispensing raw
materials or intermediates, including
B. Production Operations proper cleaning, labeling, and
environmental controls, based on the
1. Application factors type of material and manufacturing
Describe and differentiate the process being used. (Analyze)
requirements for manufacturing
processes according to their E. Requirements for
application: human or veterinary
drugs or biologics. (Apply) Critical Unit Processes
1. Process parameters
2. Utility requirements Use required CPPs for such unit
Identify the facility and utility processes as sterilization or
requirements that are appropriate sterilizing filtration, aseptic filling,
for different production environments depyrogenation, lyophilization,
and product types, including sterile other drying processes, tablet
vs. nonsterile manufacturing, solid granulation and compression,
and semisolid dosage forms, terminal sterilization, cream or
liquids, creams, ointments, and ointment emulsification. (Apply)
combination products. (Analyze)
2. Validation studies
3. Sanitization and protection Explain and evaluate the
Identify various production validation studies, specifically the
operations that require gowning, methodologies and acceptance
sanitization, hygiene, and other criteria, required before
product-protective steps. (Apply) implementing critical unit processes.
Explain and evaluate validation
C. In-process Controls studies such as requirements for
1. In-process testing aseptic processes including process
simulations (“media fills”), and
Identify appropriate tests for each temperature controls. (Evaluate)
step in the manufacturing process
and review results. (Analyze) 3. Unit operations
2. Critical process parameters (CPPs) Assess unit processes or their
validations for deviations requiring
Monitor CPPs. (Analyze) investigation. (Analyze)
3. Process capability studies 4. Operating procedures
Review process capability studies, Review qualification and
and calculate Cp and Cpk. (Apply) validation results and confirm that
they are reflected in operating
4. Specification limits
procedures. (Analyze)
Assess specification limits
in relation to registration or 5. Re-evaluation and revalidation
compendial requirements. Determine appropriate criteria
(Evaluate) and frequency for re-evaluation
and revalidation of unit processes.
D. Dispensing and Weighing Controls (Evaluate)
1. Staging areas
6. Environmental
Review product dispensing and
monitoring requirements
after-dispensing staging areas to
determine if they meet requirements. Differentiate between environmental
(Apply) monitoring requirements for different
manufacturing area classifications.
(Apply)

14 Certified Pharmaceutical GMP Professional


7. Environmental monitoring tools
Describe and use various monitoring
tools to measure viable and
nonviable particulates, pressure
differentials, temperature, and
humidity. (Apply)

F. Contamination and
Cross-contamination
1. Sources
Identify potential sources for
these events. (Apply)

2. Risk mitigation
Describe and apply various
techniques for mitigating the
risk of these events, including
cleaning, facility, utility and
equipment design, material
and personnel flow, qualified
disinfectants, operator training,
validation, and monitoring. (Apply)

G. Reprocessed and
Reworked Materials
1. Disposition process
Distinguish reprocessing from
reworking and apply appropriate
documentation, approval, and
disposition methods for these
materials. (Apply)

2. Storage
Describe and apply requirements
for segregation and secure storage
of these materials. (Apply)

VII. Filling, Packaging,


Labeling (18 Questions)
A. Filling Operations and Controls
1. Materials control
Develop and review procedures
to ensure the identity, strength,
and purity of specified materials
(e.g., liquids, powders, ointments,
tablets, capsules, suspensions)
and to prevent them from being
altered. (Create)

Certified Pharmaceutical GMP Professional 15


2. Filling equipment control C. In-process and
Analyze the controls needed Finished Goods Inspections
for various types of production
1. Inspections
equipment and processes and
ensure that the appropriate controls Develop criteria for in-process and
are in place to verify filling criteria. finished goods inspections of filled
(Analyze) and packaged materials, including
seal tests, torque testing, and bottle
3. Contamination controls rejection systems. (Create)
Identify controls to prevent
2. Vision and detection systems
microbial and other contamination
at all stages of filling. (Apply) Ensure that vision and detection
systems are qualified, calibrated,
4. Staged materials and challenged as required for the
Review staged materials and system. (Apply)
confirm that they are approved for
3. Defect characterizations
use. (Apply)
Ensure that defect characterizations
5. Status labeling are identified for each product
Identify and apply proper status and can be detected by inspection
labeling throughout the process. or test. (Apply)
(Apply)
4. Equipment failure detection
Confirm by inspection or test
B. Environmental Monitoring that equipment failures can be
Use various monitoring techniques detected. (Apply)
(active air sampling, settling plates,
swab sampling, nonviable particle
counting, contact plates for surfaces D. Product Inspection
and people) to determine that 1. Staff evaluation
appropriate environmental conditions Ensure that staff who perform
are maintained during production manual and semi-automatic
operations. (Apply) inspections are properly trained
and that their inspections meet
reproducibility requirements.
(Apply)

16 Certified Pharmaceutical GMP Professional


2. Inspector requirements F. Labeling Operations and Controls
Establish requirements for 1. Label printing in packaging
inspectors to have periodic eye
Confirm and document that any
examinations. Confirm and
printing done separately or in the
document that they take frequent
course of packaging is performed
breaks from inspection. (Apply)
correctly. (Apply)
3. Automated inspection processes
2. Quality of print used
Ensure that automated inspection
Ensure that any type of print
processes are validated. (Apply)
information (engraved, embossed)
on packaging materials is clear
E. Packaging Operations and Controls and resistant to fading, smudging,
1. Content protection or erasure. (Apply)
Develop and apply procedures to
3. Label changes
prevent the environment or events
from altering the identity, strength, Determine whether regulatory
purity and quality of the package notification and approval is
content. (Create) required for proposed label
changes. (Analyze)
2. Qualification and
maintenance of equipment 4. Label reconciliation
Ensure that equipment used in Confirm that label reconciliation is
packaging operations is qualified performed and documented and
and maintained. (Apply) discrepancies are investigated.
(Analyze)
3. Line clearance operations
5. Unused labels
Determine that line clearance
is performed and documented. Confirm that procedures are in
(Apply) place and in use for controlled,
unused batch-coded labels and
4. Quality check criteria labeling materials. (Apply)
Identify and apply specified 6. Label production
criteria when quality checks are
performed. (Apply) Define terms related to offline
printing, roll label splicing, gang
5. Cut-label procedures printing, secure storage and
Apply appropriate procedures for destruction, (Understand)
cut labels, splices. (Apply) 7. Access control
6. Hand-applied label procedures Ensure that controls are in place
Ensure that hand-applied labels for the creation, storage, and
are 100% inspected. (Apply) issuance of labels. (Apply)

7. Packaging controls G. Filling and Packaging Records


Distinguish between controls 1. Terms
needed for different types of Define terms related to these
packaging processes. records, including evidence of
line clearance, printed material
8. Contamination controls reconciliation, and yields.
Identify controls to prevent (Understand)
microbial and other contamination
at all stages of packaging. (Apply) 2. Setup instructions
Ensure that packaging line setup
9. Tamper-evident packaging instructions are appropriate for all
Ensure that tamper-evident and components. (Apply)
child-proof packaging requirements
are in place for required products.
(Apply)

Certified Pharmaceutical GMP Professional 17


VIII. Product Development C. Raw Materials, Packaging,
and Infrastructure for
and Technology Transfer
Product Development
(13 Questions) Select appropriate development studies
A. Quality by Design Concepts for raw material selection and evaluate
the results to determine their critical
1. Critical quality attributes quality attributes. (Analyze)
(CQAs) and critical process
parameters (CPPs) D. New Product Development
Identify CQAs for products and Studies and Reports
CPPs for processes. (Evaluate) Analyze studies and reports, including
stability reports, material compatibility,
2. Design space
method development, and development
Define the concept of design space reports to support product development
as it is used throughout the product and submissions. (Evaluate)
life cycle. (Understand)

3. Process analytical E. Scale-up and Transfer Activities


technology (PAT) tools 1. Development and
Identify PAT tools, including validation principles
multivariate data analysis, process Identify and distinguish development
analyzers, process and endpoint and validation studies. (Understand)
controls, and describe their use
in supporting the manufacture of 2. Technology transfer types
quality products. (Remember) Define different types of technology
transfer, including manufacturing
B. Phase-appropriate site change, analytical laboratory
GMP Requirements site change, and analyze inter-site
comparison of results. (Analyze)
1. Product life cycle development
Apply phase appropriate GMPs 3. Successful technology transfer
throughout the product life cycle. Define various studies, including
(Understand) ranging, capability, in-process
control, hold times, and shipping
2. Development phases to ensure successful transfer
Identify recommendations between development and
and requirements in relation to commercial processes. (Evaluate)
phases of development, including
method qualification/validation,
comparability protocols, and
adoption of critical process
parameters and specifications.
(Understand)

3. Combination products
Identify GMP requirements
and various studies required for
combination drug-device or drug-
delivery products. (Understand)

4. Clinical trials material


Describe and apply requirements
for production and packaging of
clinical trials material/investigational
medicinal products (IMPs). (Apply)

18 Certified Pharmaceutical GMP Professional


LEVELS OF COGNITION
Based on Bloom’s Taxonomy—Revised (2001)

In addition to content specifics, the subtext for each topic in this BoK also
indicates the intended complexity level of the test questions for that topic.
These levels are based on “Levels of Cognition” (from Bloom’s Taxonomy—
Revised, 2001) and are presented below in rank order, from least complex
to most complex.

REMEMBER | Recall or recognize terms, EVALUATE | Make judgments about the


definitions, facts, ideas, materials, patterns, value of proposed ideas, solutions, etc.,
sequences, methods, principles, etc. by comparing the proposal to specific
criteria or standards.
UNDERSTAND | Read and understand
descriptions, communications, reports, CREATE | Put parts or elements together
tables, diagrams, directions, regulations, etc. in such a way as to reveal a pattern or
structure not clearly there before; identify
APPLY | Know when and how to use which data or information from a complex
ideas, procedures, methods, formulas, set is appropriate to examine further or
principles, theories, etc. from which supported conclusions can
be drawn.
ANALYZE | Break down information into
its constituent parts and recognize their
relationship to one another and how they
are organized; identify sublevel factors or
salient data from a complex scenario.

Visit asq.org/cert for comprehensive exam information.


Enhance your career
with ASQ certification today!

Visit asq.org/cert for additional


certification information including:

• Applications

• Available certifications and


international language options

• Reference materials

• Study guides and test-taking tips

• Comprehensive exam information

• ASQ sections

• International contacts

• Endorsements

Item B1638

You might also like